Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...

Healthcare stocks have lagged the market for years, but 2026 is looking much better.

VanEck Biotech ETF receives a Hold rating due to mixed outlooks among its top holdings and unattractive valuation metrics. BBH's heavy concentration in Amgen, Gilead Sciences, and Vertex ...

Dividend strategies are off to a strong start in 2026. Here are three of the best to consider for the long term.

Health care has re-emerged as a favored allocation as markets grow more selective following a volatile 2025. Analysts say the shift reflects both valuation discipline and improving earnings visibility ...

The Vanguard Growth ETF and Invesco QQQ Trust are great growth index ETFs. The Global X Artificial Intelligence & Technology ETF is a nice AI-focused fund that also gives investors exposure to ...